Navigation Links
Mindray Announces Partnership with Epiphany Cardiography Products, LLC
Date:11/28/2011

SHENZHEN, China, Nov. 28, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced a strategic North American partnership with Epiphany Cardiography Products, LLC, of Midlothian, Virginia. Under this partnership, Mindray's 12-Lead cardiac monitoring data will be integrated into Epiphany's pure web browser-based, user-friendly Cardio Server application, which receives, manages and exports diagnostic test results from over 100 devices to Electronic Medical Records (EMRs).

"Interoperability is at the core of all Mindray development. The open architecture of Epiphany's Cardio Server gives our customers the advantage they seek in device integration and information access," said Michael Mullen, Business Manager for Systems and Networking, Mindray North America. "Since efficiency is of utmost importance in healthcare, caregivers can now combine state-of-the-art monitoring from Mindray with the enterprise-wide productivity solutions provided by Cardio Server."

Mindray's 12-Lead cardiac monitoring data, which includes continuous 12-Lead ST and arrhythmia analyses, allows users to get a picture of patients' hearts before they exhibit symptoms, or as they recover. Cardio Server lets users acquire, edit, confirm and print quality 12-Lead ECGs from virtually anywhere as long as they have access to a web browser. In addition, ECGs are accessible from the iPad™, iPhone™ or Android™ devices. Such ease of access can save time and even lives in face of cardiac problems.

"We believe this is only the beginning of our integration with Mindray. The possibilities of our collaboration are endless," said Joe Noto, Epiphany's VP of Strategic Alliances, Partnerships and Marketing. "We are thrilled to be moving forward with Mindray to continually improve workflow and quality of care."  

About MindrayWe are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com.

About EpiphanyEpiphany, founded in 2004, simplifies the collection and management of diagnostic test results. With over 330 hospital users in the US and abroad, Epiphany's continued success is fueled by innovation and a commitment to exceptional customer service. For more information about Epiphany Cardiography Products or Cardio Server, please visit http://www.epiphanycardio.com. For investors please contact:In the U.S.Hoki LukWestern Bridge, LLCTel: +646-808-9150 Email: hoki.luk@westernbridgegroup.com In China:Cathy GaoMindray Medical International LimitedTel: +86-755-8188-8023Email: cathy.gao@mindray.com
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mindray to Hold Annual General Meeting in Hong Kong on December 19, 2011
2. Mindray Announces Up to $100 Million Share Repurchase Program
3. Mindray Announces Third Quarter 2011 Financial Results
4. Mindray Medical to Exhibit at MEDICA 2011 in Dusseldorf, Germany from November 16-19, 2011
5. Mindray Medical to Exhibit New Products at 66th China International Medical Equipment Fair
6. Mindray to Report Third Quarter 2011 Financial Results on November 7, 2011
7. Mindray Introduces Enhancements for M Series Ultrasound Platforms at ASA
8. Mindray Announces Expansion of its A Series Anesthesia Portfolio
9. Mindray Introduces DP-50 Portable Ultrasound System in the U.S.
10. Mindray Announces Second Quarter 2011 Financial Results
11. Mindray to Report Second Quarter 2011 Financial Results on August 8, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create ... it streamlines the reporting process and provides a familiar interface that does not ...
(Date:4/28/2017)... ... ... sleep affects much more than energy – it also has mental and physical benefits. According ... reaction time, which can increase the risk of having a car accident. , This ... NSF to help you sleep better and feel better:, , Turn ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... exposed to more adverse experiences than children in the general population. That’s because ... abuse, neglect or other family challenges. While no fault of their own, youth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
Breaking Medicine News(10 mins):